Rumored Buzz on cgmp compliance
No. 21 CFR 211.113(a) requires appropriate published procedures being set up and followed all through manufacturing to prevent objectionable microorganisms in drug products and solutions not necessary to be sterile. On top of that, the next paragraph of USP Normal Chapter Antimicrobial Success Screening reads: Antimicrobial preservatives s